NCT02033876View on ClinicalTrials.gov

Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

March 31, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Ursodiol

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER